| N06CA03 |
N06CA03 fluoxetine and psycholeptics |
| N06CB |
N06CB Psychostimulants In Combination With Psycholeptics |
| N06D |
N06D Anti-dementia drugs |
| N06DA |
N06DA Anticholinesterases |
| N06DA01 |
N06DA01 tacrine |
| N06DA02 |
N06DA02 Donepezil |
| N06DA03 |
N06DA03 Rivastigmine |
| N06DA04 |
N06DA04 Galantamine |
| N06DA05 |
N06DA05 Ipidacrine |
| N06DA52 |
N06DA52 Donepezil and memantine |
| N06DA53 |
N06DA53 Donepezil, memantine et Ginkgo folium |
| N06DX |
N06DX Other anti-dementia drugs |
| N06DX01 |
N06DX01 Memantine |
| N06DX02 |
N06DX02 Ginkgo folium |
| N06DX03 |
N06DX03 Aducanumab |
| N06DX04 |
N06DX04 Lecanemab |
| N06DX05 |
N06DX05 Donanemab |
| N06DX06 |
N06DX06 Blarcamesin |
| N06DX07 |
N06DX07 Hydromethylthionine |
| N06DX30 |
N06DX30 Combinations |
| N07 |
N07 Other nervous system drugs |
| N07A |
N07A Parasympathomimetics |
| N07AA |
N07AA Anticholinesterases |
| N07AA01 |
N07AA01 Neostigmine |
| N07AA02 |
N07AA02 Pyridostigmine |
| N07AA03 |
N07AA03 distigmine |
| N07AA30 |
N07AA30 ambenonium |
| N07AA51 |
N07AA51 neostigmine, combinations |
| N07AB |
N07AB Choline Esters |
| N07AB01 |
N07AB01 carbachol |